Readout Newsletter: Immunovant, Roivant, Sanofi, Regeneron
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Tag: Sanofi
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease
Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the ...
Feds threaten Sanofi over proposed 340B changes
A U.S. government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to ...
Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M
Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being acquired by Recordati in ...
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval ...
We’re reading about Medicare drug prices, a Sanofi MS pill
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on our ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!